Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05526443 · clinicaltrials.gov ↗

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Advanced Pancreatic Carcinoma

Interventions

DRUG: all approved chemotherapeutic agents from second line

Sponsor

Medical University of Graz